It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre. […]
CCO to provide Ga-Octreotate to Ontario patients free of charge in Sherbrooke
A message from Helena Senta:
“At this time, CCO is proceeding with […]
Thank you to all our donors and volunteers!
As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their […]
Campaign Shines Spotlight on Rare Cancer on November 10th –World NET Cancer Day
Toronto, ON – November 10th, 2016 – Today is World NET Cancer Day. To raise […]
“LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer
Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare […]
Clinical benefit demonstrated with everolimus and pasireotide LAR alone or in combination in the first randomised, prospective study entirely dedicated to advanced lung and thymic carcinoids.
In patients with advanced lung […]
CNETS Canada is looking to gain insight into the Canadian neuroendocrine (NET) cancer patient experience with Gallium 68 scans to date. This information will assist us in developing next steps […]
One way that CNETS Canada honours those individuals who have made an outstanding commitment and contribution to the NET cancer patient community is through our annual Maureen Coleman award. Maureen […]
Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors (PET/Ga68)
Phase-II, prospective, open label, no control group to assess the safety of 68Ga-DOTA-TATE injection […]